Literature DB >> 27190834

Protection Provided by Hepatitis B Vaccine in Adult Population of Chaharmahal and Bakhtiari Province, Iran in 2013.

Masoumeh Moezzi1, Reza Imani2.   

Abstract

INTRODUCTION: Hepatitis B vaccination has been integrated into National Expanded Program on Immunization in Iran since the year 1993 and young adult national vaccination project was done in 2008. So we have three subpopulations with vaccination coverage for hepatitis B and different antibody levels. Consisting of Subpopulation 1 born after 1993, subpopulation 2 born between 1989 and 1993 and receiving vaccination under adult national project, and subpopulation 3 born prior to the year 1989. AIM: The present study was conducted to investigate community protection by hepatitis B vaccine in adult population in an accessible population in Iran and compare vaccination coverage, HBs Ab level, and its effective titration among the three above-mentioned subpopulations.
MATERIALS AND METHODS: This cross-sectional study was done on a 3000-individual adult population from all seven counties of Chaharmahal and Bakhtiari province enrolled by clustering. After obtaining written consent and filling out a questionnaire of demographic data and history of hepatitis B vaccination by trained interviewers, necessary blood sample was taken and HBs Ab titration was checked. The data were analysed by chi-square in SPSS 19. The level of significance was considered as 0.05 and effective Ab titration as ≥ 10.
RESULTS: The mean age of the participants was 38.4±16.3 years. Of the participants 48.2% had effective titration. For vaccination coverage, 77.4% were unvaccinated, 20% completely vaccinated, and 2.6% incompletely vaccinated with a significant association with effective titration (p<0.001). Eighty six percent of the subpopulation 1 and 79% of the subpopulation 2 were completely vaccinated, with a significant difference in effective titration between them (p<0.001). Vaccination coverage was higher in men and the single but equal in cities and villages. The effective titration was significantly associated with being married and residence place (p=0.003). There was a significant association between effective titration and the time at vaccination (p<0.001).
CONCLUSION: Protection provided by hepatitis B vaccine in adult population is relatively suitable especially in the youth population; however, catch-up programs of the groups exposed to risk are recommended.

Entities:  

Keywords:  Effective titration; HBs Ab level; Vaccination coverage

Year:  2016        PMID: 27190834      PMCID: PMC4866132          DOI: 10.7860/JCDR/2016/17758.7548

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  19 in total

Review 1.  Epidemiology of hepatitis B in Europe and worldwide.

Authors:  Miriam J Alter
Journal:  J Hepatol       Date:  2003       Impact factor: 25.083

2.  Changing seroprevalence of hepatitis B virus markers of adults in Singapore.

Authors:  Wei Wei Hong; Li Wei Ang; Jeffrey L Cutter; Lyn James; Suok Kai Chew; Kee Tai Goh
Journal:  Ann Acad Med Singapore       Date:  2010-08       Impact factor: 2.473

3.  A community-based sero-epidemiological study of hepatitis B infection in Lianyungang, China, 2010.

Authors:  Zhang Ting-Lu; Xiao Zhi-Ping; Ling Hong-Yu; Ge Chang-Hong; Ying Liang; Ding Qiang; Xu Kai-Ling; Mao Yan-Ming; Du Yue-He; Zhu Ling-Yang
Journal:  Western Pac Surveill Response J       Date:  2012-08-03

Review 4.  Long-term protection provided by hepatitis B vaccine and need for booster dose: a meta-analysis.

Authors:  Jalal Poorolajal; Mahmood Mahmoodi; Reza Majdzadeh; Siavosh Nasseri-Moghaddam; AliAkbar Haghdoost; Akbar Fotouhi
Journal:  Vaccine       Date:  2009-11-01       Impact factor: 3.641

5.  High non-responsiveness of males and the elderly to standard hepatitis B vaccination among a large cohort of healthy employees.

Authors:  Angelique P A Vermeiren; Christian J P A Hoebe; Nicole H T M Dukers-Muijrers
Journal:  J Clin Virol       Date:  2013-07-26       Impact factor: 3.168

6.  Seroepidemiology of HBV infection in South-East of iran; a population based study.

Authors:  M Salehi; S M Alavian; S V Tabatabaei; Sh Izadi; E Sanei Moghaddam; S Amini Kafi-Abad; A Gharehbaghian; S Khosravi; H Abolghasemi
Journal:  Iran Red Crescent Med J       Date:  2012-05-30       Impact factor: 0.611

7.  Distribution and risk factors of hepatitis B virus infection in the general population of Central Iran.

Authors:  Mohammad Reza Ghadir; Mojtaba Belbasi; Akram Heidari; Mahboobeh Jandagh; Iman Ahmadi; Hosseinali Habibinejad; Alireza Kabiri; Amir Hossein Ghanooni; Abolfazl Iranikhah; Seyed Moayed Alavian
Journal:  Hepat Mon       Date:  2012-02-29       Impact factor: 0.660

8.  Natural History and Clinical Consequences of Hepatitis B Virus Infection.

Authors:  Calvin Q Pan; Jin X Zhang
Journal:  Int J Med Sci       Date:  2005-01-05       Impact factor: 3.738

9.  Seroprevalence of Hepatitis B Virus Infection and Its Risk Factors in the West of Iran: A Population-based Study.

Authors:  Seyed Moayed Alavian; Seyed Vahid Tabatabaei; Teyyeb Ghadimi; Farzam Beedrapour; Sedigheh Amini Kafi-Abad; Ahmad Gharehbaghian; Hassan Abolghasemi
Journal:  Int J Prev Med       Date:  2012-11

10.  Seroprevalence of hepatitis B surface antigen and anti hepatitis C antibody in zahedan city, iran: a population-based study.

Authors:  Alireza Ansari-Moghaddam; Mohammad Reza Ostovaneh; Batool Sharifi Mood; Esmail Sanei-Moghaddam; Amirhossein Modabbernia; Hossein Poustchi
Journal:  Hepat Mon       Date:  2012-09-30       Impact factor: 0.660

View more
  1 in total

Review 1.  Knowledge, Vaccination Status, and Reasons for Avoiding Vaccinations against Hepatitis B in Developing Countries: A Systematic Review.

Authors:  Putri Bungsu Machmud; Saskia Glasauer; Cornelia Gottschick; Rafael Mikolajczyk
Journal:  Vaccines (Basel)       Date:  2021-06-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.